Safety, pharmacokinetics, and preliminary activity of the α-specific PI3K inhibitor BYL719: Results from the first-in-human study Meeting Abstract
| Authors: | Gonzalez-Angulo, A. M.; Juric, D.; Argilés, G.; Schellens, J. H. M.; Burris, H. A.; Berlin, J.; Middleton, M. R.; Schuler, M. H.; Van Geel, R.; Helgason, T.; Bootle, D.; Boehm, M.; Goggin, T. K.; Demanse, D.; Quadt, C.; Baselga, J. |
| Abstract Title: | Safety, pharmacokinetics, and preliminary activity of the α-specific PI3K inhibitor BYL719: Results from the first-in-human study |
| Meeting Title: | 49th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 31 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2013 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2013-05-20 |
| Language: | English |
| ACCESSION: | WOS:000335419601049 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2013.31.15_suppl.2531 |
| Notes: | Meeting Abstract: 2531 -- Source: Wos |
